Health Data Governance as Strategic Value Driver

Roland Berger frames data governance as a strategic enabler for M&A, AI, and market access, with cross-border implications. A Deloitte report reveals most healthcare CFOs feel unprepared for enterprise decisions, highlighting a governance gap. Enterprise AI governance is now seen as critical for ROI and risk management. Recent DOJ settlement and Regenxbio clinical hold further underscore governance failures. This shifts the narrative from compliance to value creation, directly relevant for boardroom and due diligence discussions.